Clinical Trials Logo

Pancreatic Diseases clinical trials

View clinical trials related to Pancreatic Diseases.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06463873 Not yet recruiting - Clinical trials for Kidney Transplant; Complications

A Pilot Study of OmniGraft in Simultaneous Pancreas Kidney Recipients

Start date: June 15, 2024
Phase:
Study type: Observational

The purpose of this research is learn about how OmniGraf works in kidney pancreas transplant patients. Also, to analyze the performance characteristics of OmniGrafTM (TruGraf Gene Expression Profiling (GEP) and T Cell Receptor Alpha Constant (TRAC) dd-cfDNA) in a population of simultaneous kidney pancreas transplants as a part of routine surveillance, as well as a part of the workup for patients clinically suspected to have rejection of the kidney and/or pancreas.

NCT ID: NCT05954221 Not yet recruiting - Pancreatic Diseases Clinical Trials

Red Cell Lysis Buffer Application Versus Conventional Sample Processing in EUS-FNB

Start date: September 15, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to evaluate the application of red cell lysis buffer (RCLB) versus conventional sample processing in endoscopic ultrasonography (EUS)-guided biopsy for solid pancreatic lesions. The main questions it aims to answer are: whether the application of red cell lysis buffer improves histological tissue quality by decreasing blood contamination. Participants with solid pancreatic lesions who needs histological diagnosis will receive EUS-guided biopsy. The obtained specimens will be processed by RCLB and conventional formalin solution. Researchers will compare the blood contamination score of specimens in RCLB group with the conventional group see if the blood contamination can be improved.

NCT ID: NCT05743972 Not yet recruiting - Pancreatic Disease Clinical Trials

Contrast-Enhanced Ultrasound vs Conventional US-guided Percutaneous Needle Biopsy for Pancreatic Diseases: Prospective Multicenter Randomized Controlled Trial

Start date: March 1, 2023
Phase: N/A
Study type: Interventional

According to previous studies, contrast-enhanced ultrasound (CEUS) -guided Core Biopsy(GB) could improve the diagnosis of biopsy in liver and other superficial mass compared to conventional US-GB. The purpose of this randomized trial is to estimate whether CEUS-GB achieve excellent diagnostic value to conventional US-GB in percutaneous biopsy for pancreatic diseases.

NCT ID: NCT05514470 Not yet recruiting - Clinical trials for Interstitial Lung and Liver Disease

Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress

FIBROMARS
Start date: April 2024
Phase: N/A
Study type: Interventional

Mutations in the genes encoding cytosolic aminoacyl-tRNA synthetases are responsible for early-onset multisystemic diseases including to varying degrees interstitial lung disease, liver damage, neurological and digestive disorders, and systemic inflammation. These are rare and severe diseases whose pathophysiology is poorly understood. The investigative team hypothesizes that mutations within these genes are responsible for a decrease in protein translation and lead to a cellular stress response similar to that induced by amino acid deprivation. The investigative team also hypothesizes that these alterations could be corrected by high-dose supplementation in the culture medium of the corresponding amino acid. The main objective of the study is to precisely determine the consequences of cytosolic aminoacyl-tRNA synthetase mutations at the cell level on protein translation.

NCT ID: NCT04964648 Not yet recruiting - Pancreatic Diseases Clinical Trials

Shear Wave Elastography in Diagnosis of Inflammatory and Malignant Pancreatic Diseases

Start date: July 10, 2021
Phase:
Study type: Observational

Only a few studies that have assessed the normal range value for pancreatic stiffness, inflammatory and malignant pancreatic lesions, shear wave velocities of healthy parenchyma, acute and chronic pancreatitis, malignant lesions of the pancreas will be evaluated and compared with other conventional imaging modalities, and evaluate its role in assessment of severity and prediction of clinical course/ outcome in patients with inflammatory pancreatic diseases.

NCT ID: NCT04900012 Not yet recruiting - Clinical trials for Surgery--Complications

Prospective Snapshot Audit of Distal Pancreatectomy in Spain

Spadispan
Start date: July 1, 2021
Phase:
Study type: Observational

Distal pancreatectomy is the surgical technique performed to treat many pancreatic diseases located in neck and tail of the pancreas. Laparoscopic approach is the gold standard but in many centres the percentage of laparoscopic approach is still low. This technique has low mortality but 30% morbidity mostly related to pancreatic fistula. Some new devices (linear stapler, energy devices and patches) seem to decrease pancreatic fistula but there is not evidence based medicine that confirm the results published usually in unicentric studies.

NCT ID: NCT04760847 Not yet recruiting - Pancreatitis Clinical Trials

Intermittent Fasting for Pancreatitis

IFPanc
Start date: July 7, 2024
Phase: N/A
Study type: Interventional

The purpose of this research is to compare intermittent fasting with a standard diet approach for improving the quality of life related to your pancreas disease. Our hope is to improve your symptoms and prevent you from needing to go into the hospital for pancreas-related issues.

NCT ID: NCT04153318 Not yet recruiting - Pancreatic Diseases Clinical Trials

Diagnostic Efficacy of FFOCT Imaging for Tissue Sample Obtained by EUSFNB

Start date: December 1, 2019
Phase:
Study type: Observational

In most Asian medical centers, rapid on-site cytology evaluation is not available, the number of needle passes of EUS-FNA is decided by endoscopists. Full-field optical coherence tomography (FF-OCT) is a new optical imaging technique that could generate sectioning tomogram from fresh tissue and provide close-to-pathology depiction of the morphological structure and pathological changes in minutes without conventional tissue preparation, slicing, and staining, and dynamic cell imaging (DCI) added the viability information of cells/tissue, which could be more important in sample rapid evaluation.

NCT ID: NCT01900938 Not yet recruiting - Pancreatic Diseases Clinical Trials

Comparison Between Continuous Infusion and Intermittent Bolus Injection of Propofol for Deep Sedation During ERCP

Start date: September 2013
Phase: N/A
Study type: Interventional

The aim of this study is to compare sedation efficiency, safety and satisfaction by both endoscopist, assistants, and the patients between continuous infusion and intermittent bolus injection of propofol for deep sedation during ERCP.